VIRPAX PHARMACEUTICALS, INC. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3b7a6e79-ac43-400a-99d4-cd166e66ce63/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-12.1M | 2024-01-01 – 2024-12-31 | evidence 0001731122-25-000316 |
| FY 2023 | $-15.2M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-025781 |
| FY 2022 | $-21.7M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-022071 |
| FY 2021 | $-12.1M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016740 |
| FY 2020 | $-4.3M | 2020-01-01 – 2020-12-31 | evidence 0001213900-22-016740 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).